Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.


  • Researchers discover role of microglia during early progression of Alzheimer's disease

  • Opposites don't attract when learning how to use a prosthesis

  • Scientists build a digital piece of a rat's brain

  • Researchers learn how to grow old brain cells

  • Preventing memory loss before symptoms appear

  • Sex change hormonal treatments alter brain chemistry

  • Medical diagnosis: Will brain palpation soon be possible?

  • Brain cooling lessens chances of head injury recovery, study finds

  • Extremely active rats become lazy when they artificially receive 'runners' high'

  • Scientists identify how normally protective immune responses kill neurons